Title of article :
COVID-19 in Nepal: Diagnostic and Management Dilemma
Author/Authors :
Subedi, Pramod Department of Biochemistry and Genetics - La Trobe Institute for Molecular Science - La Trobe University - Melbourne, Australia , Khadge, Rajiv Department of Pathology - Medicare National Hospital and Research Center - Kathmandu, Nepal , Timilsina, Sanjog Beni Hospital - Myagdi, Nepal , Poudel, Kritika Faculty of Health Sciences - Hokkaido University - Sapporo, Japan
Abstract :
An outbreak of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus (SARS-CoV-2) has created a global health crisis.1 Globally, there have been more than 53 million confirmed cases causing more than 1.2 million deaths.2 Although the World Health Organization (WHO) reports an overall decrease in weekly cases in Southeast Asia, COVID-19 cases are rising sharply in Nepal.3 As of November 12, 2020, Nepal has documented the pandemic in all seven provinces and 77 districts, confirming 204 242 cases and 1189 deaths (Figure 1).4 Out of the total number of confirmed cases, 164 592 cases have recovered while 38461 active cases are in self-quarantine via home isolation. Among critically ill patients with COVID-19, 379 are in the intensive care unit (ICU) from which 78 cases are on ventilation support....
Keywords :
COVID-19 , Nepal , Diagnostic , Management Dilemma , Letter to Editor
Journal title :
International Journal of Travel Medicine and Global Health
